Mirum Pharmaceuticals (NASDAQ:MIRM) and Assertio (NASDAQ:ASRT) Critical Review
Assertio (NASDAQ:ASRT – Get Free Report) and Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Valuation & Earnings This table compares Assertio and […]
More Stories
StockNews.com Begins Coverage on Golden Minerals (NYSE:AUMN)
StockNews.com began coverage on shares of Golden Minerals (NYSE:AUMN – Free Report) in a research note issued to investors on...
StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Friday. The...
StockNews.com Initiates Coverage on América Móvil (NYSE:AMX)
StockNews.com initiated coverage on shares of América Móvil (NYSE:AMX – Free Report) in a research note released on Friday morning....
Primerica (NYSE:PRI) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Primerica (NYSE:PRI – Free Report) from a hold rating to a buy rating in a research...
Zovio (NYSE:ZVO) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Zovio (NYSE:ZVO – Free Report) in a research note released on Friday. The brokerage...
StockNews.com Begins Coverage on Phoenix New Media (NYSE:FENG)
StockNews.com started coverage on shares of Phoenix New Media (NYSE:FENG – Free Report) in a research note issued to investors...